LLY Free Cash Flow
Operating cash flow less capital expenditures — the cash a business keeps after funding itself.
Free Cash Flow
Latest: $7.76B (2026Q2)
| Period | Value |
|---|---|
| 2024Q1 | $180M |
| 2024Q2 | $241M |
| 2024Q3 | $2.36B |
| 2024Q4 | $978M |
| 2025Q1 | $156M |
| 2025Q2 | $1.39B |
| 2025Q3 | $6.75B |
| 2025Q4 | $678M |
| 2026Q1 | $3.01B |
| 2026Q2 | $7.76B |
Other LLY Charts
More quarter-by-quarter fundamentals for Eli Lilly and Company
1 / 10
Revenue
EPS
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Free Cash Flow
Free Cash Flow
Free Cash Flow
Latest Free Cash Flow: $7.76B (2026Q2); +458.1% YoY.
Across the 10 quarters from 2024Q1 to 2026Q2, Free Cash Flow ranged from $156M in 2025Q1 to $7.76B in 2026Q2.